REFERENCES
- Bennett J, Wilson J, Sun D, et al. Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest Ophthalmol Vis Sci. 1994; 35: 2535–2542, [PUBMED], [INFOTRIEVE]
- Huang S P, Lin P K, Liu J H, et al. Intraocular gene transfer of ciliary neurotrophic factor rescues photoreceptor degeneration in RCS rats. J Biomed Sci. 2004; 11: 37–48, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Acland G M, Aguirre G D, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet. 2001; 28: 92–95, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Akimoto M, Miyatake S, Kogishi J, et al. Adenovirally expressed basic fibroblast growth factor rescues photoreceptor cells in RCS rats. Invest Ophthalmol Vis Sci. 1999; 40: 273–279, [PUBMED], [INFOTRIEVE], [CSA]
- McNally N, Kenna P, Humphries M M, et al. Structural and functional rescue of murine rod photoreceptors by human rhodopsin transgene. Hum Mol Genet. 1999; 8: 1309–1312, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chen J, Flannery J G, LaVail M M, et al. bcl-2 overexpression reduces apoptotic photoreceptor cell death in three different retinal degenerations. Proc Natl Acad Sci USA. 1996; 93: 7042–7047, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Roy S, Zhang K, Roth T, et al. Reduction of fibronectin expression by intravitreal administration of antisense oligonucleotides. Nat Biotechnol. 1999; 17: 476–479, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Andrews A, Balciunaite E, Leong F L, et al. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1999; 40: 2683–2689, [PUBMED], [INFOTRIEVE], [CSA]
- Kimura H, Sakamoto T, Cardillo J A, et al. Retrovirus-mediated suicide gene transduction in the vitreous cavity of the eye: feasibility in prevention of proliferative vitreoretinopathy. Human Gene Ther. 1996; 7: 799–808, [CSA]
- Hayashi N, Ido E, Ohtsuki Y, Ueno H. An experimental application of gene therapy for human retinoblastoma. Invest Ophthalmol Vis Sci. 1999; 40: 265–272, [PUBMED], [INFOTRIEVE], [CSA]
- Hurwitz M Y, Marcus K T, Chevez-Barrios P, et al. Suicide gene therapy for treatment of retinoblastoma in a murine model. Human Gene Ther. 1999; 10: 441–448, [CROSSREF], [CSA]
- Madreperla S A, Whittum-Hudson J A, Prendergast R A, et al. Intraocular tumor suppression of retinoblastoma gene-reconstituted retinoblastoma cells. Cancer Res. 1991; 51: 6381–6384, [PUBMED], [INFOTRIEVE]
- Lai C C, Wu W C, Chen S L, et al. Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin. Invest Ophthalmol Vis Sci. 2001; 42: 2401–2407, [PUBMED], [INFOTRIEVE], [CSA]
- Murata T, Cui J, Taba K E, et al. The possibility of gene therapy for the treatment of choroidal neovascularization. Ophthalmology. 2000; 107: 1364–1373, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bennett J, Duan D, Engelhardt J F, Maguire A M. Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction. Invest Ophthalmol Vis Sci. 1997; 38: 2857–2863, [PUBMED], [INFOTRIEVE], [CSA]
- Flannery J G, Zolotukhin S, Vaquero M I, et al. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc Natl Acad Sci USA. 1997; 94: 6916–6921, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Li T, Adamian M, Roof D J, et al. In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest Ophthalmol Vis Sci. 1994; 35: 2543–2549, [PUBMED], [INFOTRIEVE]
- Zufferey R, Nagy D, Mandel R J, et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol. 1997; 15: 871–875, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Miyoshi H, Takahashi M, Gage F H, Verma I M. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA. 1997; 94: 10319–10323, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Grant C A, Ponnazhagan S, Wang X S, et al. Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina. Curr Eye Res. 1997; 16: 949–956, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bennett J, Maguire A M, Cideciyan A V, et al. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci USA. 1999; 96: 9920–9925, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hauswirth W W, Beaufrere L. Ocular gene therapy: quo vadis?. Invest Ophthalmol Vis Sci. 2000; 41: 2821–2826, [PUBMED], [INFOTRIEVE], [CSA]
- Guy J, Qi X, Muzyczka N, Hauswirth W W. Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve. Arch Ophthalmol. 1999; 117: 929–937, [PUBMED], [INFOTRIEVE], [CSA]
- Politi L E, Rotstein N P, Carri N G. Effect of GDNF on neuroblast proliferation and photoreceptor survival: additive protection with docosahexaenoic acid. Invest Ophthalmol Vis Sci. 2001; 42: 3008–3015, [PUBMED], [INFOTRIEVE], [CSA]
- Miyazaki H, Okuma Y, Fujii Y, et al. Glial cell line-derived neurotrophic factor protects against delayed neuronal death after transient forebrain ischemia in rats. Neuroscience. 1999; 89: 643–647, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kitagawa H, Hayashi T, Mitsumoto Y, et al. Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats. Stroke. 1998; 29: 1417–1422, [PUBMED], [INFOTRIEVE], [CSA]
- Koeberle P D, Ball A K. Neurturin enhances the survival of axotomized retinal ganglion cells in vivo: combined effects with glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor. Neuroscience. 2002; 110: 555–567, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sakurai M, Abe K, Hayashi T, et al. Adenovirus-mediated glial cell line-derived neurotrophic factor gene delivery reduces motor neuron injury after transient spinal cord ischemia in rabbits. J Thorac Cardiovasc Surg. 2000; 120: 1148–1157, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wu W C, Lai C C, Chen S L, et al. Gene therapy for detached retina by adeno-associated virus vector expressing glial cell line-derived neurotrophic factor. Invest Ophthalmol Vis Sci. 2002; 43: 3480–3488, [PUBMED], [INFOTRIEVE], [CSA]
- Wu W C, Lai C C, Chen S L, et al. GDNF gene therapy attenuates retinal ischemic injuries in rats. Mol Vis. 2004; 10: 93–102, [PUBMED], [INFOTRIEVE], [CSA]
- Tsai T H, Chen S L, Chiang Y H, et al. Recombinant adeno-associated virus vector expressing glial cell line-derived neurotrophic factor reduces ischemia-induced damage. Exp Neurol. 2000; 166: 266–275, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Xiao X, Li J, Samulski R J. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol. 1998; 72: 2224–2232, [PUBMED], [INFOTRIEVE], [CSA]
- Xiao X, Li J, McCown T J, Samulski R J. Gene transfer by adeno-associated virus vectors into the central nervous system. Exp Neurol. 1997; 144: 113–124, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wu W C, Lai C C, Chen S L, et al. Gene therapy for detached retina by adeno-associated virus vector expressing glial cell line-derived neurotrophic factor. Invest Ophthalmol Vis Sci. 2002; 43: 3480–3488, [PUBMED], [INFOTRIEVE], [CSA]
- Fisher K J, Jooss K, Alston J, et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med. 1997; 3: 306–312, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jooss K, Yang Y, Fisher K J, Wilson J M. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol. 1998; 72: 4212–4223, [PUBMED], [INFOTRIEVE], [CSA]
- Xiao X, Li J, Samulski R J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol. 1996; 70: 8098–8108, [PUBMED], [INFOTRIEVE], [CSA]
- Dudus L, Anand V, Acland G M, et al. Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV. Vision Res. 1999; 39: 2545–2553, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Anand V, Chirmule N, Fersh M, et al. Additional transduction events after subretinal readministration of recombinant adeno-associated virus. Human Gene Ther. 2000; 11: 449–457, [CROSSREF], [CSA]
- Halbert C L, Standaert T A, Aitken M L, et al. Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J Virol. 1997; 71: 5932–5941, [PUBMED], [INFOTRIEVE], [CSA]
- Nakai H, Yant S R, Storm T A, et al. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J Virol. 2001; 75: 6969–6976, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Nakai H, Montini E, Fuess S, et al. AAV serotype 2 vectors preferentially integrate into active genes in mice. Nat Genet. 2003; 34: 297–302, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Li Z, Dullmann J, Schiedlmeier B, et al. Murine leukemia induced by retroviral gene marking. Science. 2002; 296: 497, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Marshall E. Clinical research. Gene therapy a suspect in leukemia-like disease. Science. 2002; 298: 34–35, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Marshall E. Gene therapy. Second child in French trial is found to have leukemia. Science. 2003; 299: 320, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kay M A, Nakai H. Looking into the safety of AAV vectors. Nature. 2003; 424: 251, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Tsai M L, Chen S L, Chou P I, et al. Inducible adeno-associated virus vector-delivered transgene expression in corneal endothelium. Invest Ophthalmol Vis Sci. 2002; 43: 751–775, [PUBMED], [INFOTRIEVE], [CSA]
- Chang M A, Horner J W, Conklin B R, et al. Tetracycline-inducible system for photoreceptor-specific gene expression. Invest Ophthalmol Vis Sci. 2000; 41: 4281–4287, [PUBMED], [INFOTRIEVE], [CSA]
- Tripathy S K, Black H B, Goldwasser E, Leiden J M. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med. 1996; 2: 545–550, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sakamoto T, Ueno H, Goto Y, et al. Retinal functional change caused by adenoviral vector-mediated transfection of LacZ gene. Human Gene Ther. 1998; 9: 789–799, [CSA]
- Liang F, Aleman T S, Cideciyan A V, et al. Ciliary neurotrophic factor (CNTF) delivered by adeno-associated viruses (AAV) leads to photoreceptor loss and impairs retinal function in wild-type rats. Invest Ophthalmol Vis Sci. 2003; 44, E-Abstract 3585
- Liang F Q, Aleman T S, Dejneka N S, et al. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Mol Ther. 2001; 4: 461–472, [PUBMED], [INFOTRIEVE], [CSA]
- Schlichtenbrede F C, MacNeil A, Bainbridge J W, et al. Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration. Gene Ther. 2003; 10: 523–527, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bok D, Yasumura D, Matthes M T, et al. Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal structure and function in mice with a P216L rds/peripherin mutation. Exp Eye Res. 2002; 74: 719–735, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Simon P D, Vorwerk C K, Mansukani S S, et al. bcl-2 gene therapy exacerbates excitotoxicity. Human Gene Ther. 1999; 10: 1715–1720, [CROSSREF], [CSA]
- Jin M, Chen Y, He S, et al. Hepatocyte growth factor and its role in the pathogenesis of retinal detachment. Invest Ophthalmol Vis Sci. 2004; 45: 323–329, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Humpel C, Hoffer B, Stromberg I, et al. Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation. Neuroscience. 1994; 59: 791–795, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Liberatore G T, Wong J Y, Porritt M J, et al. Expression of glial cell line-derived neurotrophic factor (GDNF) mRNA following mechanical injury to mouse striatum. Neuroreport. 1997; 8: 3097–3101, [PUBMED], [INFOTRIEVE], [CSA]
- Miyazaki H, Nagashima K, Okuma Y, Nomura Y. Expression of glial cell line-derived neurotrophic factor induced by transient forebrain ischemia in rats. Brain Res. 2001; 922: 165–172, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wang Y, Chang C F, Morales M, et al. Protective effects of glial cell line-derived neurotrophic factor in ischemic brain injury. Ann N Y Acad Sci. 2002; 962: 423–437, [PUBMED], [INFOTRIEVE], [CSA]
- Wu W C, Lai C C, Chen S L, et al. Gene therapy for detached retina by adeno-associated virus vector expressing glial cell line-derived neurotrophic factor. Invest Ophthalmol Vis Sci. 2002; 43: 3480–3488, [PUBMED], [INFOTRIEVE], [CSA]
- Huang C T, Huso D L, Lu Z, et al. CD4+ T cells pass through an effector phase during the process of in vivo tolerance induction. J Immunol. 2003; 170: 3945–3953, [PUBMED], [INFOTRIEVE]